APA

Fernández L., Leivas A., Valentín J., Escudero A., Corral D., de Paz R., Vela M., Bueno D., Rodríguez R., Torres J. M., Díaz-Almirón M., López-Collazo E., Martinez-Lopez J. & Pérez-Martínez A. (20181217). How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?. : Transfusion.

Chicago

Fernández Lucía, Leivas Alejandra, Valentín Jaime, Escudero Adela, Corral Dolores, de Paz Raquel, Vela Maria, Bueno David, Rodríguez Rebeca, Torres Juan Manuel, Díaz-Almirón Mariana, López-Collazo Eduardo, Martinez-Lopez Joaquin and Pérez-Martínez Antonio. 20181217. How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?. : Transfusion.

Harvard

Fernández L., Leivas A., Valentín J., Escudero A., Corral D., de Paz R., Vela M., Bueno D., Rodríguez R., Torres J. M., Díaz-Almirón M., López-Collazo E., Martinez-Lopez J. and Pérez-Martínez A. (20181217). How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?. : Transfusion.

MLA

Fernández Lucía, Leivas Alejandra, Valentín Jaime, Escudero Adela, Corral Dolores, de Paz Raquel, Vela Maria, Bueno David, Rodríguez Rebeca, Torres Juan Manuel, Díaz-Almirón Mariana, López-Collazo Eduardo, Martinez-Lopez Joaquin and Pérez-Martínez Antonio. How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?. : Transfusion. 20181217.